Literature DB >> 31453718

Evaluation of a new image reconstruction method for digital breast tomosynthesis: effects on the visibility of breast lesions and breast density.

Julia Krammer1, Sergei Zolotarev2, Inge Hillman3, Konstantinos Karalis3, Dzmitry Stsepankou4, Valeriy Vengrinovich2, Jürgen Hesser2,5,6, Tony M Svahn7,8.   

Abstract

OBJECTIVE: To compare image quality and breast density of two reconstruction methods, the widely-used filtered-back projection (FBP) reconstruction and the iterative heuristic Bayesian inference reconstruction (Bayesian inference reconstruction plus the method of total variation applied, HBI).
METHODS: Thirty-two clinical DBT data sets with malignant and benign findings, n = 27 and 17, respectively, were reconstructed using FBP and HBI. Three experienced radiologists evaluated the images independently using a 5-point visual grading scale and classified breast density according to the American College of Radiology Breast Imaging-Reporting And Data System Atlas, fifth edition. Image quality metrics included lesion conspicuity, clarity of lesion borders and spicules, noise level, artifacts surrounding the lesion, visibility of parenchyma and breast density.
RESULTS: For masses, the image quality of HBI reconstructions was superior to that of FBP in terms of conspicuity,clarity of lesion borders and spicules (p < 0.01). HBI and FBP were not significantly different in calcification conspicuity. Overall, HBI reduced noise and supressed artifacts surrounding the lesions better (p < 0.01). The visibility of fibroglandular parenchyma increased using the HBI method (p < 0.01). On average, five cases per radiologist were downgraded from BI-RADS breast density category C/D to A/B.
CONCLUSION: HBI significantly improves lesion visibility compared to FBP. HBI-visibility of breast parenchyma increased, leading to a lower breast density rating. Applying the HBIR algorithm should improve the diagnostic performance of DBT and decrease the need for additional imaging in patients with dense breasts. ADVANCES IN KNOWLEDGE: Iterative heuristic Bayesian inference (HBI) image reconstruction substantially improves the image quality of breast tomosynthesis leading to a better visibility of breast carcinomas and reduction of the perceived breast density compared to the widely-used filtered-back projection (FPB) reconstruction. Applying HBI should improve the accuracy of breast tomosynthesis and reduce the number of unnecessary breast biopsies. It may also reduce the radiation dose for the patients, which is especially important in the screening context.

Entities:  

Mesh:

Year:  2019        PMID: 31453718      PMCID: PMC6849672          DOI: 10.1259/bjr.20190345

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  30 in total

Review 1.  Visual grading characteristics (VGC) analysis: a non-parametric rank-invariant statistical method for image quality evaluation.

Authors:  M Båth; L G Månsson
Journal:  Br J Radiol       Date:  2006-07-19       Impact factor: 3.039

2.  The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103.

Authors: 
Journal:  Ann ICRP       Date:  2007

3.  Image artifacts in digital breast tomosynthesis: investigation of the effects of system geometry and reconstruction parameters using a linear system approach.

Authors:  Yue-Houng Hu; Bo Zhao; Wei Zhao
Journal:  Med Phys       Date:  2008-12       Impact factor: 4.071

Review 4.  Digital Breast Tomosynthesis: Physics, Artifacts, and Quality Control Considerations.

Authors:  Nikki Tirada; Guang Li; David Dreizin; Luke Robinson; Gauri Khorjekar; Sergio Dromi; Thomas Ernst
Journal:  Radiographics       Date:  2019-02-15       Impact factor: 5.333

5.  Digital breast tomosynthesis: Dose and image quality assessment.

Authors:  A Maldera; P De Marco; P E Colombo; D Origgi; A Torresin
Journal:  Phys Med       Date:  2016-12-20       Impact factor: 2.685

6.  Artifacts in Digital Breast Tomosynthesis.

Authors:  William R Geiser; Samuel A Einstein; Wei-Tse Yang
Journal:  AJR Am J Roentgenol       Date:  2018-07-31       Impact factor: 3.959

7.  Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial.

Authors:  Elizabeth A Rafferty; Jeong Mi Park; Liane E Philpotts; Steven P Poplack; Jules H Sumkin; Elkan F Halpern; Loren T Niklason
Journal:  Radiology       Date:  2012-11-20       Impact factor: 11.105

8.  Effect of reduced radiation exposure and iterative reconstruction on detection of low-contrast low-attenuation lesions in an anthropomorphic liver phantom: an 18-reader study.

Authors:  Ajit H Goenka; Brian R Herts; Nancy A Obuchowski; Andrew N Primak; Frank Dong; Wadih Karim; Mark E Baker
Journal:  Radiology       Date:  2014-03-10       Impact factor: 11.105

9.  "Memory effect" in observer performance studies of mammograms.

Authors:  Lara A Hardesty; Marie A Ganott; Christiane M Hakim; Cathy S Cohen; Ronald J Clearfield; David Gur
Journal:  Acad Radiol       Date:  2005-03       Impact factor: 3.173

10.  One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.

Authors:  Sophia Zackrisson; Kristina Lång; Aldana Rosso; Kristin Johnson; Magnus Dustler; Daniel Förnvik; Hannie Förnvik; Hanna Sartor; Pontus Timberg; Anders Tingberg; Ingvar Andersson
Journal:  Lancet Oncol       Date:  2018-10-12       Impact factor: 41.316

View more
  2 in total

1.  Comparison of Diagnostic Efficacy Between Contrast-Enhanced Ultrasound and DCE-MRI for Mass- and Non-Mass-Like Enhancement Types in Breast Lesions.

Authors:  Wei Liu; Min Zong; Hai-Yan Gong; Li-Jun Ling; Xin-Hua Ye; Shui Wang; Cui-Ying Li
Journal:  Cancer Manag Res       Date:  2020-12-31       Impact factor: 3.989

2.  DBT Masses Automatic Segmentation Using U-Net Neural Networks.

Authors:  Xiaobo Lai; Weiji Yang; Ruipeng Li
Journal:  Comput Math Methods Med       Date:  2020-01-28       Impact factor: 2.238

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.